VAXDIGM

About:

VAXDIGM focuses on the development of advanced vaccines and future vaccines.

Top Investors: TIPS Program, The Invention Lab, New Paradigm Investment, InfoBank, Korea Alternative Investment Asset Management

Description:

Total Funding Amount:

3.2B KRW

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2021-12-01

Contact Email:

hydrogold(AT)vaxdigm.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-10-23

IPO Status:

Private

Industries: